Application of dunaliella in improvement of noise aggravated atherosclerosis

By using a Donepezil preparation, the problem of aggravated atherosclerosis caused by noise exposure was solved. By reducing plaque area and increasing collagen deposition, atherosclerosis was improved and prevented.

CN118903214APending Publication Date: 2024-11-08HARBIN MEDICAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411168204.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-23
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing technologies have failed to effectively address the problem of increased atherosclerosis caused by noise exposure, as the relevant mechanisms are unclear and there is a lack of effective prevention and treatment targets and methods.

Method used

Using a Donorubicin (NYU-BL-A4) formulation, this drug is prepared via in vitro supplementation to improve or prevent noise-induced atherosclerosis, reduce aortic plaque area, increase collagen deposition, stabilize plaques, and reduce lipid deposition.

Benefits of technology

It effectively reduces the severity of atherosclerosis caused by noise, decreases aortic plaque area, increases plaque stability, reduces lipid deposition, and provides a new method for treating and preventing noise-induced atherosclerosis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903214A_ABST
    Figure CN118903214A_ABST
Patent Text Reader

Abstract

The invention discloses an application of dunaliella in improvement of atherosclerosis, relates to the field of microorganisms and biological medicines, and aims to explore the relevance between noise and atherosclerosis and establish an ApoE- / -mouse model of atherosclerosis aggravation caused by noise. The aortic root plaque area of a mouse is reduced, the aortic root collagen deposition percentage is increased, and aortic root lipid deposition is reduced, that is, the atherosclerosis aggravation degree caused by noise can be effectively reduced by supplementing dunaliella in vitro. Therefore, the dunaliella or the microbial inoculum containing the dunaliella can provide a new thought and method for relieving or eliminating the atherosclerosis aggravation degree caused by noise and also providing a new thought and method for treating or preventing atherosclerosis with noise aggravation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of microorganisms and biomedicine, and in particular relates to an application of Dunaliella in improving atherosclerosis. Background Art

[0002] Existing studies have shown that noise environment has a great impact on health and is linearly correlated with an increased risk of cardiovascular disease. Other studies have found that the correlation between road traffic noise and cardiovascular disease is stronger in subjects who sleep with windows open. In addition, based on basic experimental studies, it is known that noise exposure will increase stress hormone levels and increase oxidative stress levels in the vascular system and brain. These factors can promote vascular (endothelial) dysfunction, inflammation, and arterial hypertension, thereby increasing the risk of cardiovascular disease. Recent studies have found that noise exposure can lead to a significant increase in the incidence, severity, and risk of death of atherosclerosis, and the related mechanisms are still unclear. Based on this, this application deeply explores the mechanism of noise-related atherosclerosis and finds effective prevention and treatment targets, which is of great clinical significance.

[0003] During the research, we found that noise exposure caused significant changes in the composition, diversity and function of the intestinal microbiota. In addition, noise exposure affects the balance and correlation between host metabolic characteristics and intestinal microorganisms, and long-term exposure to noise reduces the level of intestinal tight junction proteins and increases intestinal permeability. Even out of the noise environment, this effect will not completely disappear. Therefore, correcting the imbalance of metabolites and microbiota may become a new treatment direction and target for noise-related diseases. The purpose of this application is to verify the mechanism by which noise causes changes in the intestinal flora and aggravates atherosclerosis, and to find ways to alleviate or eliminate the aggravated consequences of atherosclerosis caused by noise. At present, there are no research reports on the mechanism of noise-aggravated atherosclerosis and its prevention and treatment methods.

[0004] Introduction to atherosclerosis: The normal arterial wall has three layers of structure, inner, middle and outer membranes. The inner membrane is covered by a layer of endothelial cells, and the surface is very smooth, which can prevent harmful substances in the blood from damaging the blood vessel wall and protect the blood vessels. When the endothelial cells of the artery are damaged or aged, the lipid components in the blood (mainly cholesterol) are easy to enter the inner membrane, which then causes local fibrous tissue hyperplasia. In the early stage, some lipid stripes will appear on the surface of the blood vessel inner membrane. With the increase of lipid deposition, the lipid core wrapped by the fibrous tissue gradually increases, forming a protruding plaque, which makes the arterial wall thicker and harder, and the lumen smaller. These plaque lesions in the artery are mostly yellow granular, and the appearance looks like millet porridge, so they are called atherosclerosis. As the stenosis of the arterial lumen caused by atherosclerotic lesions worsens, the blood flow at the distal end of the artery can be reduced, and eventually cause ischemia and hypoxia of the organs and tissues supplied by the artery, such as myocardial ischemia or cerebral insufficiency. In the process of the enlargement of atherosclerotic plaques, local inflammatory reactions can also be caused. At this time, the atherosclerotic plaques become unstable, and ulcers or ruptures are prone to occur on the surface of the plaques. Summary of the invention

[0005] In view of the above situation, in order to overcome the defects of the prior art, the present invention provides an application of Bacillus durmera in improving noise-induced aggravated atherosclerosis. Bacillus durmera can be used to prepare drugs related to preventing or improving the aggravation of atherosclerosis caused by noise.

[0006] The inventors first verified through a control experiment that noise can aggravate atherosclerosis, increase plaque area and instability, and promote the occurrence and development of atherosclerosis, while oral administration of antibiotics can eliminate this effect, proving that intestinal flora plays a very important role in this.

[0007] Subsequently, the inventors conducted a control experiment of intestinal flora transplantation, and once again verified that intestinal flora plays a very critical role in noise-related atherosclerosis; and found that noise promotes the progression of atherosclerosis by reducing the abundance of intestinal Dunaliella.

[0008] Finally, the inventors verified through strain control experiments that in vitro supplementation of Dunaliella can effectively reduce the progression of noise-induced atherosclerosis.

[0009] Specifically, the present invention is realized by the following schemes: In the first aspect, the present invention provides the use of Ducromatella or a preparation containing Ducromatella in the preparation of a drug for improving atherosclerosis aggravated by noise, wherein the Ducromatella is NYU-BL-A4, and the content of Ducromatella in the drug is not less than 1.0×10 9 cfu / ml or 1.0×10 9 cfu / g.

[0010] In a second aspect, the present invention provides the use of a bacterium or a preparation containing the bacterium in the preparation of a drug for preventing atherosclerosis aggravated by noise, wherein the bacterium is NYU-BL-A4, and the content of the bacterium in the drug is not less than 1.0×10 9 cfu / ml or 1.0×10 9 cfu / g.

[0011] In three aspects, the Donornaelias or a preparation containing the Donornaelias is used to reduce aortic plaque area.

[0012] In a fourth aspect, the Bacillus duromatus or a preparation containing the Bacillus duromatus is used in at least one of the following aspects:

[0013] (a) Reduce the area of ​​plaque in the aortic root;

[0014] (b) increase the percentage of collagen deposition in the aortic root;

[0015] (c) Reduce lipid deposition in the aortic root.

[0016] Compared with the prior art, the present invention has the following beneficial effects: noise aggravates atherosclerosis, increases plaque area and instability, and establishes an ApoE marker for aggravated atherosclerosis caused by noise. - / - Mouse model, through experiments to verify that in vitro supplementation of Bacillus can reduce the aortic plaque area of ​​mice, reduce the plaque area of ​​the aortic root of mice, increase the percentage of collagen deposition in the aortic root, reduce lipid deposition in the aortic root, and make the aortic root plaque more stable and less prone to rupture, that is, in vitro supplementation of Bacillus can effectively reduce the aggravation of atherosclerosis caused by noise. Therefore, Bacillus or bacterial agents containing Bacillus can provide a way to reduce or eliminate the aggravation of atherosclerosis caused by noise, and also provide new ideas and methods for treating or preventing atherosclerosis aggravated by noise. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] The accompanying drawings are used to provide further understanding of the present invention and constitute a part of the specification. They are used to explain the present invention together with the embodiments of the present invention and do not constitute a limitation of the present invention.

[0018] Figure 1 This is an overview of the experimental grouping in Example 1 of the present invention;

[0019] Figure 2 The comparison of aortic Oil Red O staining of three groups of mice in Example 1 of the present invention (aortic plaque area);

[0020] Figure 3 This is a bar graph showing the differences in Oil Red O staining of the aortas of the three groups of mice in Example 1 of the present invention;

[0021] Figure 4 Comparison of HE staining of the aortic root of three groups of mice in Example 1 of the present invention (aortic root plaque area);

[0022] Figure 5 This is a bar graph showing the differences in HE staining of the aortic roots of the three groups of mice in Example 1 of the present invention;

[0023] Figure 6 The figure is a comparison of Masson staining of the aortic root of the three groups of mice in Example 1 of the present invention (percentage of collagen deposition in the aortic root);

[0024] Figure 7 This is a bar graph showing the difference in Masson staining of the aortic roots of the three groups of mice in Example 1 of the present invention;

[0025] Figure 8 The Oil Red O staining of the aortic root of the three groups of mice in Example 1 of the present invention is compared (aortic root plaque lipid deposition);

[0026] Fig. 9 This is a bar graph showing the differences in Oil Red O staining of the aortic roots of the three groups of mice in Example 1 of the present invention;

[0027] Fig.10 The figure is a comparison of aortic Oil Red O staining of two groups of mice in Example 2 of the present invention (aortic plaque area);

[0028] Fig.11 This is a bar graph showing the difference in Oil Red O staining of the aortas of two groups of mice in Example 2 of the present invention;

[0029] Fig.12 The figure is a comparison of Oil Red O staining of the aortic root of two groups of mice in Example 2 of the present invention (aortic root plaque lipid deposition);

[0030] Fig.13 This is a bar graph showing the difference in Oil Red O staining of the aortic roots of two groups of mice in Example 2 of the present invention;

[0031] Fig.14 Comparison of HE staining of the aortic root of two groups of mice in Example 2 of the present invention (aortic root plaque area);

[0032] Fig.15 This is a bar graph showing the difference in HE staining of the aorta root of two groups of mice in Example 2 of the present invention;

[0033] Fig.16 The figure is a comparison of Masson staining of the aortic root of two groups of mice in Example 2 of the present invention (percentage of collagen deposition in the aortic root);

[0034] Fig.17 This is a bar graph showing the difference in Masson staining of the aortic roots of two groups of mice in Example 2 of the present invention;

[0035] Figure 18-20 This is a comparison chart of α diversity and β diversity of fecal flora of two groups of mice in Example 3 of the present invention;

[0036] Figure 21-23 This is a comparison chart of the abundance of Dunaliella in the fecal flora of two groups of mice in Example 3 of the present invention;

[0037] Fig.24 This is an overview of the experimental grouping in Example 4 of the present invention;

[0038] Fig.25 The figure is a comparison of aortic Oil Red O staining of two groups of mice in Example 4 of the present invention (aortic plaque area);

[0039] Fig.26 This is a bar graph showing the difference in Oil Red O staining of the aortas of two groups of mice in Example 4 of the present invention;

[0040] Fig. 27 The figure is a comparison of Oil Red O staining of the aortic root of two groups of mice in Example 4 of the present invention (aortic root plaque lipid deposition);

[0041] Fig.28 This is a bar graph showing the difference in Oil Red O staining of the aortic roots of two groups of mice in Example 4 of the present invention;

[0042] Fig.29 Comparison of HE staining of the aortic root of two groups of mice in Example 4 of the present invention (aortic root plaque area);

[0043] Fig.30 This is a bar graph showing the difference in HE staining of the aorta root of two groups of mice in Example 4 of the present invention;

[0044] Fig.31 The figure is a comparison of Masson staining of the aortic root of two groups of mice in Example 4 of the present invention (percentage of collagen deposition in the aortic root);

[0045] Fig.32 This is a bar graph showing the difference in Masson staining of the aortic roots of two groups of mice in Example 4 of the present invention.

[0046] in, Figures 2 to 9 In the figure, from left to right, the relevant test data of the control group (Nc), the noise exposure group (Noise), and the antibiotic group (Noise+ABX) in Example 1 are shown;

[0047] Figure 10-17 In the figure, from left to right, the relevant test data of the autologous fecal transplantation group (NC-FMT) and the noise fecal transplantation group (Noise-FMT) in Example 2 are shown;

[0048] Figure 25-32 In the figure, from left to right are the relevant detection data of the noise+solvent control group (Noise) and the noise+Dunnovella group (Noise+DN) in Example 4.

[0049] It should be noted that in the accompanying drawings, a P value <0.05 was considered statistically significant (Note: * indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001, **** indicates P < 0.0001, and ns indicates P > 0.05). DETAILED DESCRIPTION

[0050] The present invention discloses an application of Bacillus durmex in improving noise-aggravated atherosclerosis. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters to achieve the application. It should be particularly noted that all similar substitutions and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention. The method and application of the present invention have been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications described herein without departing from the content, spirit and scope of the present invention to implement and apply the technology of the present invention.

[0051] Among them, the establishment of animal models: giving ApoE - / - Mice (8-week-old male, 18-22g) were fed with high-fat (40% fat, 1.25% cholesterol) for 12 weeks to establish an atherosclerosis animal model. The high-fat and high-cholesterol feed (40% fat; 1.25% cholesterol) of the XT108C series of Jiangsu Collaborative Medicine Bioengineering Co., Ltd. was used, and the control feed was the XT102C series feed of the same company.

[0052] Homozygous Apoe knockout mice lack APOE protein and develop normally but show significantly increased total plasma cholesterol levels and spontaneous atherosclerotic lesions. This model can be used to study the role of APOE in lipid metabolism, atherosclerosis, and neural damage, as well as to study interventional therapies that can alter the process of atherosclerosis.

[0053] Noise exposure conditions: pre-recorded aircraft noise was played back with an average sound pressure level of 72dB(A) and a peak sound pressure level of 85dB(A) for 4 hours per day, and the remaining 20 hours were kept under normal conditions.

[0054] Tissue frozen sections (used for aortic root oil red O staining): ApoE - / -After the mouse was anesthetized and killed, the surface and interior of the tissue were cleaned with ice-bath saline. The aortic root was retained. Specific steps:

[0055] (1) Fixation: Soak the aortic root in 4% paraformaldehyde for 48 hours;

[0056] (2) Gradient dehydration: remove the aortic root tissue from the paraformaldehyde and place it in 10% sucrose for 6 hours, 20% sucrose for 6 hours, and 30% sucrose for 12 hours at room temperature;

[0057] (3) Embedding: Inject the embedding agent into the embedding box containing the aortic root to avoid tissue displacement;

[0058] (4) Sectioning: After freezing, remove the aortic root tissue from the embedding box, place a razor blade in place, slice to a thickness of 5 μm, and store the tissue sections frozen.

[0059] Tissue paraffin sections (for HE staining and Masson staining of aortic root): ApoE - / - After the mouse was anesthetized and killed, the surface and interior of the tissue were cleaned with ice-bath saline. The aortic root was retained. Specific steps:

[0060] (1) Fixation: Place in 4% paraformaldehyde for 48 hours;

[0061] (2) Running water flushing: flush the tissue with running tap water overnight;

[0062] (3) Dehydration: Place the embedding cassettes in a dehydration machine in order, soak in 75% ethanol for 1.5 hours, 85% ethanol for 1.5 hours, 95% ethanol I and II for 1.5 hours each, anhydrous ethanol I and II for 45 minutes each, xylene I and II for 50 minutes each. Soak in paraffin I, paraffin II, and paraffin III for 1.5 hours each;

[0063] (4) Embedding: Take out the embedding box and immerse it in the paraffin tank. Use electric heating tweezers to pick up the tissue in the embedding box and place it in the mold. Slowly and evenly inject paraffin wax, place it on the base, and cool it on the cooling table. After the wax block solidifies, remove the mold and store it in a dry place at room temperature.

[0064] (5) Sectioning: Adjust the blade and slice at a thickness of 5 μm. After spreading the slides in 50°C distilled water, place the slides in a 60°C oven overnight and then store them in a dry place at room temperature.

[0065] Example 1

[0066] Verify that noise can aggravate atherosclerosis (noise can aggravate atherosclerosis, increase the area and instability of plaques, and noise exposure can promote the occurrence and development of atherosclerosis) and is related to intestinal flora. The established animal model was divided into three groups, with reference to Figure 1, respectively:

[0067] Noise exposure group (Noise): 20 mice were selected; they were exposed to noise for 4 hours a day and kept under normal conditions for the remaining 20 hours.

[0068] Antibiotic group (Noise+ABX): 20 mice were selected and raised under normal conditions.

[0069] Control group (Nc): 20 mice were selected and raised under normal conditions.

[0070] The experimental period was 12 weeks, and three groups of mice were fed a high-fat diet (HFD).

[0071] The above three groups of mice were tested from two aspects:

[0072] The first is the aortic plaque area, which is detected by staining the mouse aorta with Oil Red O;

[0073] The second is the plaque area, collagen deposition percentage and lipid deposition at the aortic root. The larger the plaque area, the smaller the corresponding collagen deposition percentage, the more unstable the aortic root plaque is and the easier it is to rupture. The detection methods of the plaque area, collagen deposition percentage and lipid deposition at the aortic root are: HE staining of the aortic root, Masson staining, and Oil Red O staining. Figure 2-9 .

[0074] From the above test results, we can know that in terms of aortic plaque area ( Figure 2-3 ), which shows that noise exposure can lead to ApoE - / - The aortic plaque area of ​​mice increased, while the aortic plaque area of ​​the antibiotic group was significantly reduced compared with the noise group.

[0075] In terms of aortic root detection ( Figure 4-9 ), it can be seen that compared with the control group, the aortic root plaque area of ​​the noise group increased significantly, and the aortic root plaque area of ​​the antibiotic group decreased; the aortic root plaque area of ​​the noise group mice increased significantly, the percentage of collagen deposition decreased significantly, and the lipid deposition of the aortic root plaque increased significantly; among them, through Figure 4 It can be observed that the plaque area of ​​the noise group increases significantly. Figure 6 and 7 It can be seen that the percentage of collagen deposition corresponding to the plaque part in the noise group is reduced, so the stability of the aortic root plaque is weakened and it is more likely to rupture.

[0076] The above test results suggest that noise exposure can promote the occurrence and development of atherosclerosis. Noise can significantly aggravate atherosclerosis and increase the plaque area and instability. Gavage with antibiotics can eliminate this effect, proving that intestinal flora plays a very important role in it.

[0077] The detection methods involved in this embodiment include aortic Oil Red O staining, aortic root HE staining, Masson staining, and Oil Red O staining.

[0078] 1. Aortic Oil Red O Staining: ApoE - / - After the mouse was anesthetized and killed, the aorta was dissected, and the residual blood on the tissue surface and in the cavity was washed away with pre-cooled saline, and the residual liquid on the tissue was absorbed with filter paper. The specific steps are as follows:

[0079] (1) Fixation: Soak the aorta in 4% paraformaldehyde for 48 hours;

[0080] (2) Gradient dehydration: remove the aorta tissue from the paraformaldehyde and place it in 10% sucrose for 6 hours, 20% sucrose for 6 hours, and 30% sucrose for 12 hours at room temperature;

[0081] (3) Staining: The aorta was cut open with the front side facing up, incubated in 60% isopropanol for 1 minute, and then placed in Oil Red O staining solution. The aorta was placed in a 37°C water bath and stained for 20 minutes in the dark.

[0082] (4) Differentiation: ApoE - / - The mouse aorta was placed in isopropanol for differentiation for 1 min, and the excess Oil Red O stain was washed off;

[0083] (5) Photographing: The aorta was fully unfolded and fixed on a vinyl dish, and photographed with a high-definition camera;

[0084] (6) Image J was used to count the Oil Red O-positive staining area and the total area of ​​the aorta, and Graphpad Prism 9 was used for analysis and graphing.

[0085] 2. Oil Red O staining of aortic root: quickly take out frozen sections from -80℃ freezer, place in a wet box, warm to room temperature, wipe off the liquid around the tissue with filter paper, and mark the tissue with a pathology marker. Specific steps:

[0086] (1) Place tissue sections in 60% isopropanol for 10 seconds;

[0087] (2) Use the freshly prepared Oil Red O staining solution, place the tissue sections in the Oil Red O staining solution, and incubate for 15 minutes in the dark;

[0088] (3) Place tissue sections in 75% anhydrous ethanol for 5 seconds and wash with distilled water;

[0089] (4) Place the tissue section in hematoxylin staining solution to stain the nucleus for 30 seconds and then quickly rinse with tap water;

[0090] (5) Place tissue sections in PBS and let stand for 5 minutes;

[0091] (6) Gently shake off the excess liquid on the slide and seal the slide with glycerol-gelatin sealing medium;

[0092] (7) Observation and statistics: The tissue was observed under a microscope, photographed and saved, and the Oil Red O positive staining area was counted by Image J. Graphpad Prism 9 was used for analysis and graphing.

[0093] 3. Specific steps of HE staining of aortic root:

[0094] (1) Take ApoE - / - Paraffin sections of mouse aortic root tissue were sequentially immersed in xylene, anhydrous ethanol, 95% ethanol, 90% ethanol, 80% ethanol, 75% ethanol, and distilled water for 5 minutes each;

[0095] (2) Place the tissue sections in a staining box containing hematoxylin staining solution for 2.5 minutes and then quickly rinse with running distilled water for 10 minutes;

[0096] (3) Stain the sections in eosin solution for 1.5 minutes;

[0097] (4) The sections were immersed in 95% alcohol, anhydrous ethanol, and xylene for 5 minutes each.

[0098] (5) Take out the slices and seal them with neutral gum;

[0099] (6) Observe tissue staining under a microscope, take photos and save them, and analyze the images using Image J.

[0100] 4. Specific steps of Masson staining of aortic root:

[0101] (1) Take ApoE - / - Paraffin sections of mouse aortic root tissue were sequentially immersed in xylene, anhydrous ethanol, 95% anhydrous ethanol, 90% anhydrous ethanol, 80% anhydrous ethanol, 75% anhydrous ethanol, and distilled water for 5 minutes each;

[0102] (2) Wipe away the residual liquid around the tissue with filter paper, place the slices in Weiger iron hematoxylin staining solution for 8 minutes, and rinse the slices with running tap water for 1 minute;

[0103] (3) Wipe away the residual liquid around the tissue with filter paper, cover the tissue with acidic ethanol differentiation solution for 10 seconds, and rinse the slices with running water for 5 minutes;

[0104] (4) Wipe away the residual liquid around the tissue with filter paper, add Masson blueing solution to cover the tissue for 2 minutes, rinse the slices with running water for 5 minutes, and rinse with distilled water for 1 minute;

[0105] (5) Wipe away the residual liquid around the tissue with filter paper, add Ponceau fuchsin solution to stain for 8 minutes, and rinse the sections with running tap water for 1 minute;

[0106] (6) Prepare a weak acid working solution in a ratio of 2:1 between distilled water and weak acid solution, and rinse the sections with the weak acid working solution for 1.5 minutes;

[0107] (7) Wipe away the residual liquid around the tissue with filter paper, incubate the tissue with 1% phosphomolybdic acid aqueous solution for 2 minutes, and rinse the slices with weak acid working solution for 1 minute;

[0108] (8) Wipe away the residual liquid around the tissue with filter paper, add aniline blue staining solution for 2 minutes, and rinse the group sections with weak acid working solution for 1 minute;

[0109] (9) Wipe the remaining liquid around the tissue with filter paper, add it to 95% ethanol for 5 seconds, and then to anhydrous ethanol for 10 seconds;

[0110] (10) Immerse the sections in xylene for three times, 2 minutes each time;

[0111] (11) Seal the slide with neutral gum;

[0112] (12) Observe tissue staining under a microscope, take photos and save them, and analyze the images using Image J.

[0113] Example 2

[0114] Based on Example 1, a secondary experiment was designed to verify the correlation between intestinal flora and noise-induced aggravation of atherosclerosis. The established animal model was divided into two groups:

[0115] Autologous fecal transplantation group (NC-FMT): 20 mice were selected; fecal microbiota transplantation was performed three times a week, 200ul each time, for a total of 12 weeks to recolonize the intestinal microbiota;

[0116] Noise-FMT group: 20 mice were selected; fecal microbiota transplantation was performed three times a week, 200ul each time, for a total of 12 weeks to recolonize the intestinal microbiota;

[0117] Among them, the fecal bacteria samples for transplantation were prepared: the donor mice were divided into a control group (ApoE - / - ; male; n = 20) and noise group (ApoE - / -; male; n = 20). Fecal samples of the two groups of mice were collected daily from the 12th week of noise intervention and stored in sterile EP tubes. 1 ml of sterile PBS buffer was added to each 150 mg of feces for dilution and homogenization. The bacteria-rich supernatant was collected after centrifugation (2,000 g, 10 minutes), centrifuged again (15,000 g, 5 minutes), and the bacterial pellet was washed twice with PBS, resuspended with 700 μl of saline containing 20% ​​glycerol, and stored in a -80C refrigerator.

[0118] ApoE - / - - Intestinal preparation is required before the first fecal microbiota transplantation in mice: receptor ApoE - / - Before fecal microbiota transplantation, mice drank drinking water containing mixed antibiotics. The antibiotic drinking water formula included: vancomycin (250 mg / L), metronidazole (500 mg / L), neomycin sulfate (500 mg / L) and ampicillin (500 mg / L) for a total of 14 days.

[0119] After treatment, the antibiotic solution was replaced with clean water, and fecal microbiota transplantation began after a 2-day washout period. The recipient mice received fecal microbiota transplantation from each donor group of mice by oral gavage (three times a week, 200ul each time) for 12 consecutive weeks.

[0120] The degree of atherosclerosis of the two groups of mice was tested in two aspects: one is the aortic plaque area; the other is the plaque area, collagen deposition percentage and lipid deposition at the aortic root. The detection method is referred to Example 1, and the detection results are referred to Figure 10-17 .

[0121] From the above test results, we can know that in terms of aortic plaque area ( Figure 10-11 ), it can be seen that compared with the self-fecal microbiota transplantation group, the noise fecal microbiota transplantation group had a lower ApoE - / - Increased plaque area in the aorta of mice.

[0122] In terms of aortic root detection ( Figure 12-17 ), it can be seen that compared with the self-fecal microbiota transplantation group, the noise fecal microbiota transplantation group had a lower ApoE - / - The plaque area in the aortic root of mice increased, the percentage of collagen deposition decreased, the plaque stability decreased, and the plaque lipid deposition increased.

[0123] Based on the above experimental results, it is once again verified that intestinal flora plays a very critical role in noise-related atherosclerosis.

[0124] Example 3

[0125] Based on the above examples 1 and 2 verifying that intestinal flora plays a very critical role in noise-related atherosclerosis, fecal samples of mice in the noise group and the control group in Example 1 were selected for 16S analysis and it was found that the α diversity and β diversity of the fecal flora of the two groups of mice changed significantly ( Figure 18-20 ), we found that the abundance of D. newyorkensis in the noise group was significantly decreased among the top ten differential bacteria, and the difference was the most obvious. D. newyorkensis is a D. newyorkensis that has been discovered. Therefore, we used quantitative PCR to verify the abundance of D. newyorkensis in the feces of the two groups of mice ( Figure 21-23 ), and finally found that the abundance of Dunaliella in the noise group was significantly reduced. Therefore, we speculate that noise promotes the progression of atherosclerosis through the reduction of Dunaliella.

[0126] Among them, the detection process of Duchennea: (prepare eight-tube without enzyme, enzyme-free pipette tip, etc. in advance, and operate on ice)

[0127] (1) Fecal DNA extraction

[0128] 1) Take 250 mg of feces and put it in a 2 ml centrifuge tube, add 1 ml of Buffer SW, vortex for 4 minutes, and centrifuge at 12,000 rpm for 1 minute at 4°C after homogenization, and discard the supernatant;

[0129] 2) Add 1 ml of Buffer SL, vortex for 4 minutes, homogenize and seal, heat in a 60°C water bath for 15 minutes, vortex every 4 minutes;

[0130] 3) Centrifuge at 12,000 rpm for 3 minutes at 4°C and transfer the supernatant to a new centrifuge tube;

[0131] 4) Add an equal volume of Buffer GL, mix well, and place on ice for 5 minutes. Centrifuge at 12,000 rpm for 5 minutes at 4°C;

[0132] 5) The supernatant was transferred to an adsorption column and centrifuged, 500 μl of Buffer GW1 was added, and the waste liquid was discarded after centrifugation;

[0133] 6) Add 500 μl Buffer GW2 and centrifuge to discard the waste liquid. Centrifuge for 2 minutes and then discard the waste liquid.

[0134] 7) Add 50 μl of Buffer GE to the adsorption column. After 5 minutes, centrifuge at 12,000 rpm for 1 minute at 4°C.

[0135] 8) After testing the concentration, transfer the DNA solution to a new centrifuge tube and store it at -20°C.

[0136] (2) qRT-PCR

[0137] 1) Reaction system: DNA 2ul, upstream primer 0.5ul, downstream primer 0.5ul, enzyme-free water 7ul, dye 10ul;

[0138] 2) Reaction program: 50°C for 2 min, 95°C for 10 min, 95°C for 15 s, 60°C for 30 s, 72°C for 30 s, 50 cycles;

[0139] 3) Melting curve program: 95℃ for 15 seconds, 60℃ for 1 minute, 95℃ for 30 seconds, 60℃ for 15 seconds;

[0140] 4) 2-ΔΔCT calculation results.

[0141] (3) 16S rRNA sequencing: two groups of ApoE - / - 5-8 fecal samples from mice were commissioned to a third-party company, Baiqu Bio, for 16S rRNA detection and analysis.

[0142] Example 4

[0143] To verify the conclusion drawn in Example 3 that Duchennea can improve or eliminate noise-induced atherosclerosis, refer to Fig.24 , the mice were divided into two groups (both were raised under noise exposure conditions):

[0144] Noise+solvent control group (Noise): 20 mice were selected and intragastrically administered with 0.2 ml of sterile PBS buffer three times a week;

[0145] 20 mice were selected in the Noise+DN group; 1×10 9 CFU / ml solution of D. cerevisiae, 0.2 ml peroral administration, three times a week. D. cerevisiae is NYU-BL-A4.

[0146] After 12 weeks, a follow-up experiment was conducted to test the degree of atherosclerosis in the two groups of mice: one is the aortic plaque area; the other is the plaque area, collagen deposition percentage and lipid deposition at the aortic root. The detection method is referenced to Example 1, and the detection results are referenced to Figure 25-32 .

[0147] From the above test results, we can know that in terms of aortic plaque area ( Figure 25-26 ), it can be seen that compared with the noise + solvent control group, the noise + Dunaliella group ApoE - / - The area of ​​aortic plaque was reduced in mice.

[0148] In terms of aortic root detection ( Figure 27-32 ), it can be seen that compared with the noise + solvent control group, the noise + Dunaliella group ApoE - / -The area of ​​plaques in the aortic root of mice was reduced, the percentage of collagen deposition was increased, the stability of plaques in the aortic root was increased, and the lipid deposition in plaques in the aortic root was reduced. This shows that in vitro supplementation of Dunaliella can effectively reduce the progression of atherosclerosis caused by noise.

[0149] Among them, the culture method of Duchennea NYU-BL-A4 is:

[0150] ①Accurately weigh and melt the BHI broth according to the ratio of the medium formula, stirring continuously during the process to prevent the medium from sticking to the bottom;

[0151] ② Transfer the prepared culture medium to a conical flask for high-pressure sterilization. After the culture medium is sterilized, dispense it into 15 ml sterile centrifuge tubes;

[0152] ③ Bacterial inoculation: Thaw the glycerol stock of NYU-BL-A4 of D. cerevisiae stored at -80°C, extract 100ul of the bacterial solution and inoculate it into the 10ml BHI liquid culture medium prepared in advance, culture it in an anaerobic chamber at 37°C for 24 to 36 hours, and then subculture it twice with an inoculum volume of 1mL / 100mL to fully activate the strain.

[0153] In summary, Examples 1-3 can verify that noise exposure can aggravate atherosclerosis in mice, and intestinal flora plays a very important role in this. The key strain, Bacillus dumitrinii, was found through 16s sequencing. In Example 4, Bacillus dumitrinii was gavaged and its beneficial effect on improving atherosclerosis was found. The mechanism between Bacillus dumitrinii and noise-induced aggravation of atherosclerosis was explored, and Bacillus dumitrinii or bacterial agents containing Bacillus dumitrinii can be used to prepare drugs or products related to atherosclerosis that alleviate or prevent noise-induced aggravation.

[0154] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. Use of Bacillus durmera or a preparation containing Bacillus durmera in the preparation of a drug for improving atherosclerosis aggravated by noise, characterized in that: The Donornaea bacterium is NYU-BL-A4.

2. The use according to claim 1, characterized in that: The application of the duroblastoma or a preparation containing the duroblastoma in preparing a drug for preventing atherosclerosis aggravated by noise.

3. The use according to claim 1 or 2, characterized in that: The content of Ducromatitis in the drug is not less than 1.0×10 9 cfu / ml or 1.0×10 9 cfu / g.

4. The use according to claim 1 or 2, characterized in that: The duroblastoma or the preparation containing the duroblastoma is used for reducing the area of ​​aortic plaque.

5. The use according to claim 1 or 2, characterized in that: The duromatobacterium or the preparation containing the duromatobacterium is used in at least one of the following aspects: (a) Reduce the area of ​​plaque in the aortic root; (b) increase the percentage of collagen deposition in the aortic root; (c) Reduce lipid deposition in the aortic root.